Repaglinide Tablet
Product Images NDC 71335-2598

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Repaglinide (NDC 71335-2598). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352598)

This is a description of Repaglinide tablets containing 2 mg of the active ingredient. The tablets are packaged in a container with specific NDC information. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The tablets are intended for use by prescription only and the product is manufactured by Macleods Pharmaceuticals Ltd. and repackaged by Bryant Ranch Prepack, Inc. in Burbank, CA. The warning to keep all drugs out of reach of children is highlighted in the text.*

FDA Label Image

505 (Repaglinide Figure 1)

This is a graph showing the change in HbA1c percentage over different treatment weeks for Pioglitazone. The x-axis represents treatment weeks, while the y-axis shows the change in HbA1c percentage.*

FDA Label Image

Str (Repaglinide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.